184 related articles for article (PubMed ID: 18161120)
1. [FACT study].
Tanaka I; Oshima H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():280-5. PubMed ID: 18161120
[No Abstract] [Full Text] [Related]
2. [Efficacy and tolerability of once-weekly administration of 35 mg alendronate and 17.5 mg risedronate].
Kishimoto H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():365-8. PubMed ID: 18161133
[No Abstract] [Full Text] [Related]
3. [FACT study: benefits of alendronate].
MMW Fortschr Med; 2005 Jan; 147(1-2):52-3. PubMed ID: 15704574
[No Abstract] [Full Text] [Related]
4. [HIP study--how to prevent hip fractures?].
Itabashi A
Nihon Rinsho; 2007 Nov; 65 Suppl 9():286-92. PubMed ID: 18159711
[No Abstract] [Full Text] [Related]
5. [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly].
MMW Fortschr Med; 2006 Jun; 148(25):60-1. PubMed ID: 16859169
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-International.
Reid DM; Hosking D; Kendler D; Brandi ML; Wark JD; Marques-Neto JF; Weryha G; Verbruggen N; Hustad CM; Mahlis EM; Melton ME
Int J Clin Pract; 2008 Apr; 62(4):575-84. PubMed ID: 18324951
[TBL] [Abstract][Full Text] [Related]
8. [Bisphosphonates for osteoporosis].
Narusawa K; Nakamura T
Nihon Rinsho; 2007 Nov; 65 Suppl 9():311-5. PubMed ID: 18161123
[No Abstract] [Full Text] [Related]
9. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
[TBL] [Abstract][Full Text] [Related]
10. [New bone density conservation agents for osteoporosis under research and development: PTH (1-34)].
Endo I; Matsumoto T
Nihon Rinsho; 2007 Nov; 65 Suppl 9():443-6. PubMed ID: 18161146
[No Abstract] [Full Text] [Related]
11. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
Bize R; Lamy O; Peytremann-Bridevaux I
Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286
[No Abstract] [Full Text] [Related]
12. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
[No Abstract] [Full Text] [Related]
13. [Calcium gaps in osteoporosis patients close. Blister pack simplifies comedication of calcium and bisphosphonates].
MMW Fortschr Med; 2005 Apr; 147(14):44. PubMed ID: 15887685
[No Abstract] [Full Text] [Related]
14. What's the story with Fosamax? Recent reports have women wondering if they should stop taking this widely prescribed osteoporosis drug.
Harv Womens Health Watch; 2008 Nov; 16(3):1-2. PubMed ID: 19043857
[No Abstract] [Full Text] [Related]
15. Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study.
Boonen S; Orwoll ES; Wenderoth D; Stoner KJ; Eusebio R; Delmas PD
J Bone Miner Res; 2009 Apr; 24(4):719-25. PubMed ID: 19049326
[TBL] [Abstract][Full Text] [Related]
16. Risedronate rapidly reduces the risk for nonvertebral fractures in women with postmenopausal osteoporosis.
Harrington JT; Ste-Marie LG; Brandi ML; Civitelli R; Fardellone P; Grauer A; Barton I; Boonen S
Calcif Tissue Int; 2004 Feb; 74(2):129-35. PubMed ID: 14648009
[TBL] [Abstract][Full Text] [Related]
17. Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.
Adachi JD
Can Fam Physician; 1998 Feb; 44():327-32. PubMed ID: 9512836
[TBL] [Abstract][Full Text] [Related]
18. [Evidence and utility of etidronate for the treatment of osteoporosis].
Takada J; Iba K; Yamashita T; Yoshizaki T
Clin Calcium; 2008 Oct; 18(10):1427-33. PubMed ID: 18830039
[TBL] [Abstract][Full Text] [Related]
19. Yearly zoledronic acid in postmenopausal osteoporosis.
Karam R; Camm J; McClung M
N Engl J Med; 2007 Aug; 357(7):712-3; author reply 714-5. PubMed ID: 17703529
[No Abstract] [Full Text] [Related]
20. [Osteoporosis therapy. Bisphosphonates compared].
MMW Fortschr Med; 2003 Mar; 145(13):60. PubMed ID: 15101545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
